• PL-METADUO-P35
1 1

Dual multi-receptor and amylin-pathway research blend

META-DUO Retatrutide + Cagrilintide Research Pen

META-DUO Retatrutide + Cagrilintide Research Pen

Retatrutide (LY3437943) + Cagrilintide (AM833)

Dhs. 1,099.00 AED
Dhs. 1,099.00 AED
Sale Sold out
Strength

Disclaimer

For research purposes only. Peptiva Labs products are supplied exclusively for scientific laboratory research and analytical purposes. They are not intended for human or animal use, and must not be misused in any way that contravenes applicable laws.

  • Research Grade Peptides – batch documentation available where supplied
  • Supplied in sterile, flip-top vials designed for laboratory use
  • Handled as a research-use laboratory supply only

All Peptiva Labs peptides are supplied strictly for research and laboratory use only. Each vial contains sterile, lyophilised powder that has been finely milled and sieved to ensure consistency. The stated weight refers to the content of a single vial. Reconstitution requires bacteriostatic water containing 0.9% benzyl alcohol, or a suitable equivalent. We do not offer any advice or recommendations regarding dosage, administration, or use in humans or animals.

META-DUO combines retatrutide and cagrilintide in one 3 mL pre-filled research pen for controlled laboratory studies of multi-receptor metabolic signaling, amylin-family pathways and formulation compatibility.

Specifications

Active material
Retatrutide (LY3437943) + Cagrilintide (AM833)
Declared presentation
30 mg retatrutide + 5 mg cagrilintide; 35 mg total per pen
Container
3 mL nominal cartridge; one pre-filled, pre-mixed blend pen
Nominal concentration
11.67 mg/mL total nominal; 10 mg/mL retatrutide and 1.67 mg/mL cagrilintide
CAS number(s)
No single blend CAS. Retatrutide: 2381089-83-2. Cagrilintide: 1415456-99-3.
Molecular formula
Retatrutide C221H342N46O68. Cagrilintide reference C194H312N54O59S2.
Sequence / structure
Retatrutide is a 39-residue acylated multi-receptor agonist peptide. Cagrilintide is a 37-residue lipidated amylin analog.
Synonyms
LY3437943 + AM833; retatrutide / cagrilintide research blend

What this material is studied for
  • GCGR, GLP-1R, GIPR and amylin/calcitonin-family receptor signaling assays.
  • Combination-pathway, receptor cross-talk and cAMP-response research.
  • Analytical compatibility, stability and concentration-ratio studies.

Scientific context

Retatrutide is designed to activate GCGR, GLP-1R and GIPR. Cagrilintide is a long-acting amylin analog studied at amylin and calcitonin-family receptors. This exact co-formulation requires its own analytical and experimental validation.

Storage and handling

Store the pre-mixed research pen refrigerated at 2–8 °C (36–46 °F). Keep it protected from direct light and do not freeze. The product label, assigned expiry date and formulation-specific stability data take precedence.

View full details